Bionest Partners and Scisive Consulting Merge
News Jan 29, 2013
Success in today’s competitively evolved medical industry requires insightful strategy informed by operating practicalities. Bionest Partners has combined with Scisive Consulting to create a new model consulting firm intensely responsive to, and highly qualified for, the planning needs of a new generation of medical business leaders and investors. This fusion of two highly-respected medical business consultancies equips us to deal with the new demands of the medical marketplace, and also enables each to augment its intellectual capital and expand its geographic coverage.
Bionest Partners’ new senior management team will be Alain J. Gilbert and Bob J. Easton, as Co-Chair, together with partners Dr. Mary Koto, Catharine Staughton, Olivier Lesueur and Dr. Sean Hu, offering:
• Complementarity of leadership, at once Strategic with Bob J. Easton and Operational with Alain J. Gilbert, to guarantee our clients "Practical Operability" of our recommendations
• Broader sector and deeper functional expertise: drugs/devices/diagnostics (including personalized medicine); research/development/marketing/planning/pricing/corporate development
• Personalized Medicine Strategy, widely recognized consulting expertise
• Geographic reach, with offices in Paris, London, New York, San Diego and affiliates in Munich and Tokyo
Patients in a new Northwestern Medicine study were able to comprehend words that were written but not said aloud. They could write the names of things they saw but not verbalize them. This provides an insight into the brain degeneration that defines the rare dementia termed primary progressive aphasia.